Doctors ought to think about no matter whether their patients with underlying NAION possibility components might be adversely affected by utilization of PDE5 inhibitors. Individuals who have previously knowledgeable NAION are at increased risk of NAION recurrence. For that reason, PDE5 inhibitors, such as LEVITRA, must be applied with warning in th